Richard E. Chinnock

TL;DR: Institutional Affiliations Chair Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA Task Force 1 Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland Clinic Foundation, Cleveland, Ohio, USA; Starlings R: University of Chicago, Chicago, Illinois,USA; Chan M: university of Alberta, Edmonton, Alberta, Canada ; Desai S: Inova Fairfax Hospital, Fairfax, Virginia, USA.

TL;DR: Cardiac transplantation can be performed in infants with hypoplastic left heart syndrome with good operative and intermediate-term results and improved survival can be achieved with increased donor availability, better management of rejection, and control of graft vasculopathy.

TL;DR: Identification of viral genome, particularly adenovirus, in the myocardium of pediatric transplant recipients is predictive of adverse clinical events, including coronary vasculopathy and graft loss.

TL;DR: Parvovirus genome identified through PCR analysis of cardiac tissue in the clinical setting of myocarditis and cardiac allograft rejection may be a potential contributor to cardiac transplant rejection.

TL;DR: Neurodevelopmental deficits are prevalent among school-aged children with HLHS, regardless of surgical approach, and complications that result in prolonged hospitalization at the time of the initial operation are associated with neurodevelopmental status at school age.